Article Data

  • Views 1240
  • Dowloads 112

Original Research

Open Access

Peptide YY producing strumal carcinoid tumor of the ovary

  • K. Matsunami1
  • H. Takagi1
  • S. Ichigo1
  • T. Murase2
  • T. Ikeda2
  • A. Imai3,*,

1Departments of Obstetrics and Gynecology, Matsunami General Hospital, Gifu, Japan

2Departments of Pathology, Matsunami General Hospital, Gifu, Japan

3Institute of Endocrine-Related Cancer, Matsunami General Hospital, Gifu, Japan

DOI: 10.12892/ejgo201102201 Vol.32,Issue 2,March 2011 pp.201-202

Published: 10 March 2011

*Corresponding Author(s): A. Imai E-mail: aimai@matsunami-hsp.org.jp

Abstract

Background: Primary ovarian carcinoid tumor is uncommon and represents less than 0.1% of ovarian malignancies. The strumal carcinoid may be complicated by carcinoid syndrome induced by peptide YY (PYY). Case report: We describe a 45-year-old woman with a bilateral ovarian tumor diagnosed through periodical gynecological examination. She presented with severe constipation. Right ovarian cyst laparoscopically resected was diagnosed as a strumal carcinoid tumor; the left one was mature cystic teratoma. No metastatic findings were seen macroscopically on the ovarian surface and pelvic peritoneum. Constipation was drastically improved by resecting the tumor. The carcinoid tumor cells were positive for tumor-producing PYY by mRNA analysis. Conclusion: It is important to be aware of this entity in the pathological diagnosis of ovarian tumors, in the presence of any clinical indicator of carcinoid tumor/syndrome, as it carries a markedly better prognosis and clinical outcome in comparison with most other malignant ovarian tumors.

Keywords

Ovarian strumal carcinoid; PYY; Carcinoid syndrome

Cite and Share

K. Matsunami,H. Takagi,S. Ichigo,T. Murase,T. Ikeda,A. Imai. Peptide YY producing strumal carcinoid tumor of the ovary. European Journal of Gynaecological Oncology. 2011. 32(2);201-202.

References

[1] Díaz-Montes T., Rosenthal L., Bristow R., Grumbine F.: “Primary insular carcinoid of the ovary”. Gynecol. Oncol., 2006, 101, 175.

[2] Somak R., Shramana M., Vijay S., Nita K.: “Primary carcinoid tumor of the ovary: a case report”. Arch. Gynecol. Obstet., 2008, 277, 79.

[3]

Matsuda K., Maehama T., Kanazawa K.: “Strumal carcinoid tumor of the ovary: a case exhibiting severe constipation associated with PYY”. Gynecol. Oncol., 2002, 87, 143.

[4]

Alosi J., McFadden D., Peptide Y.Y.: “Mediates inhibition of tumor growth and inflammation”. Methods Mol. Biol., 2009, 512, 377.

[5] Shigeta H., Taga M., Kurogi K., Kitamura H., Motoyama T., Gorai I.: “Ovarian strumal carcinoid with severe constipation: immunohistochemical and mRNA analyses of peptide YY”. Hum. Pathol., 1999, 30, 242.

[6] Armes J., Ostör A.: “A case of malignant strumal carcinoid”. Gynecol. Oncol., 1993, 51, 419.

[7] Robboy S., Scully R.: “Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid”. Cancer, 1980, 46, 2019.

[8] Khadilkar U., Pai R., Lahiri R., Kumar P.: “Ovarian strumal carcinoid-report of a case that matastasized”. Indian J. Pathol. Microbiol., 2000, 43, 459.

Submission Turnaround Time

Top